🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas McFall

Medical College of Wisconsin

ORCID: 0000-0002-5284-6994
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma”.

Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma

Gastroenterology(2024)10.1053/j.gastro.2024.01.028
N/A
0.515DataRank · unranked
30 citations

Olga Kudryashova, Andrey Kravets, Samih Z Thalji, Subramaniam Malarkannan, Razelle Kurzrock +21 more

Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-0018
N/A
0.208DataRank · unranked
3 citations

G. Aaron Hobbs, Raven Davidson, Daniel Dorbin, J.J. Gómez Herrera, John F. Langenheim +22 more

KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery

The Oncologist(2021)10.1002/onco.13702
N/A
0DataRank · unranked
14 citations

Thomas McFall, Kenta Takahashi, Kasey Bamel, Sadakatsu Ikeda, Ramez N. Eskander +5 more

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

npj Precision Oncology(2022)10.1038/s41698-022-00329-w
N/A
0DataRank · unranked
19 citations

Michael Trogdon, Anita C. Guizar, John F. Langenheim, Laura Sisk-Hackworth, Edward C. Stites +1 more

Mathematical modeling suggests 14-3-3 proteins modulate RAF paradoxical activation

PLoS Computational Biology(2025)10.1371/journal.pcbi.1013297
N/A
0DataRank · unranked
0 citations

Kodye L. Abbott, Yaocheng Li, Jingting Yu, Peter Carlip, Melinda Tong +6 more

Discernment between candidate mechanisms for KRAS G13D colorectal cancer sensitivity to EGFR inhibitors

Cell Communication and Signaling(2020)10.1186/s12964-020-00645-3
N/A
0DataRank · unranked
26 citations

Noah K. Schomburg, Kent L. Rossman, Edward C. Stites, Thomas McFall

Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK/MAPK Signaling and Apoptosis Induction

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0281
N/A
0DataRank · unranked
0 citations

Lucas Bialousow, Thomas McFall, Logan Bamonte, Grayson Johnson, Merissa Smith +7 more

Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach

Cell Reports(2021)10.1016/j.celrep.2021.110096
N/A
0DataRank · unranked
28 citations

Edward C. Stites, Thomas McFall